ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 375162 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 375162; 2) Community: the network communities that were significantly associated with the response to NSC 375162; 3) Molecule: the relationships between components within communities and NSC 375162; 4) MDR: the compounds that were significantly associated with the NSC 375162.

NSC Compound Enrichment Correlation
NSC 364170 3,13-Ethano-1H,10H-furo[3,4-c]furo[2',3':6,7]naphtho[2,3-b]pyran-3(3aH)-carboxylic acid, 4,5,6a,7,7a,8,12a,13-octahydro-4,14,15-trihydroxy-8,12a-dimethyl-5,10-dioxo-, methyl ester, [3S-(3.alpha.,3a.a 0.0430505868034764 0.35509429
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.0438391811600412 0.37287918
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0438391811600418 0.2697872
NSC 662383 2-Bromo-5,8-dihydroxy-3-methyl-1,4-naphthoquinone 0.0438391811600418 0.4866066
NSC 677249 Null 0.0438391811600418 0.44395778
NSC 749147 Null 0.0438391811600418 0.40243882
NSC 104801 Cytembena 0.0478540623811426 0.13356428
NSC 105132 Deoxycamptothecin 0.0478540623811426 0.38799366
NSC 113423 NSC 113423 0.0478540623811426 0.14990064
NSC 132277 Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) 0.0478540623811426 0.45345381
Total:112  Current:102    [First] [Prev] [Next] [Last]